Founder And Chief Executive Officer
@ Stealth Technology Newco
AeroLeads people directory · profile
Alicyn Campbell Email & Phone Number
Founder and Chief Executive Officer
at
@ Stealth Technology NewCo
1 work email found
@astrazeneca.com
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
@ Stealth Technology NewCo
Role
Founder and Chief Executive Officer
Location
United States
Who is Alicyn Campbell? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Alicyn Campbell is listed as Founder and Chief Executive Officer at @ Stealth Technology NewCo, based in United States. AeroLeads shows a work email signal at astrazeneca.com and a matched LinkedIn profile for Alicyn Campbell.
Alicyn Campbell previously worked as Independent Advisor for Healthcare and Life Sciences at Evidentley and Founder and Strategic Lead at Patient Relevant Evidence. Alicyn Campbell holds Master Of Public Health (Mph), Epidemiology And Health Outcomes Research from The University Of Connecticut School Of Medicine.
Company email context
Email format at @ Stealth Technology NewCo
This section adds company-level context without repeating Alicyn Campbell's masked contact details.
{first}.{last}@astrazeneca.com
86% confidence
AeroLeads found 1 current-domain work email signal for Alicyn Campbell. Compare company email patterns before reaching out.
Profile bio
About Alicyn Campbell
Decorated Industry Senior-Executive with a track record of building and scaling high performing, multidisciplinary, scientific, and technical teams. Throughout my career at multiple large Pharma, designed, developed, and deployed novel primary and secondary endpoints of treatment effect as well as multi-modal digital products. Most recently served as VP & Head of Digital Health Oncology at AstraZeneca, and Chief Scientific Officer of Evinova, a division of AstraZeneca, where my team deployed clinical trial digital health solutions reaching 59000+ oncology patients, in 100+ clinical trials in less than 4 years.I have over 17 years of research experience in Oncology Health Outcomes Research. Prior to joining AstraZeneca, served as the Global Head of Patient Centered Outcomes Research at Genentech/Roche. In that capacity, I was responsible for leadership in the assessment of the patient experience and consulted widely with the FDA and international regulators & achieved the first ever novel FDA patient reported outcome data approved in label for Hycela and was also responsible for novel patient-reported efficacy data included in approved labeling for Hemlibra.My leadership has been externally recognized with two recent industry awards: the CNS Summit Digital Innovation Index Nov 2023 and the Reuter’s Trailblazing Women in Pharma award March 2024.I have authored many significant scientific publications and presentations, primarily focused on methodology, and the measurement of treatment effectiveness and treatment tolerability in oncology.____Head of a large, multi-disciplinary team of data scientists, digital & behavioral scientists, clinical outcomes assessment scientists, product owners, delivery and implementation experts, ux/ui designers, human factors experts in addition to technical product leads. Together, we're building transformative clinical trial endpoints and products for all patients. Our team is focused on leveraging emerging technology to increase the evidence base for new medicines while improving healthcare. Combining technology and digital tools, we're working to reduce healthcare disparities and increase the heterogeneity of patients who participate in clinical research. This includes RCT's as well as pragmatic trials leveraging RWE and new technology (AI/ML, advanced analytics, multi-omics), with a specific focus on multi-modal evidence collection for novel digital therapeutics in the routine care setting.
Listed skills include Oncology, Clinical Development, Clinical Trials, Outcomes Research, and 26 others.
Current workplace
Alicyn Campbell's current company
Company context helps verify the profile and gives searchers a useful next step.
@ Stealth Technology Newco
13 roles
Alicyn Campbell work experience
A career timeline built from the work history available for this profile.
Independent Advisor For Healthcare And Life Sciences
Current
Evidentley
Strategic advising for Healthcare and Life Sciences, including access to a full team for end-to-end solution development and deployment. Please get in touch if we may be of assistance for your project: alicyn.campbell@evidentley.com
Aug 2024 - Present
Founder And Strategic Lead
Current
Patient Relevant Evidence
Strategic advising to optimize your patient-centric evidence generationFocused on non-profit and academic research grants
Feb 2019 - Present
Chief Scientific Officer
Nov 2023 - Jul 2024
Vp, Head Of Digital Health For Oncology R&D
Head of Digital Health across all of Oncology R&D. This includes but is not limited to: secondary data use, cohort analysis, digital therapeutics, regulatory grade multi-modal evidence collection, large scale predictive modeling and advanced data analytics. Additionally we are hiring out a new Advanced Analytics team, as well as a Digital Health Measurement Science team, focused on novel digital symptom collection for use in trials as well as routine care. Our internally designed and built Remote Patient Monitoring solutions have reached over 4000 clinical trial patients.
Nov 2022 - Feb 2024
Head Of Digital Health For Oncology R&D
Head of Digital Health across all of Oncology R&D. This includes but is not limited to: secondary data use, cohort analysis, digital therapeutics, regulatory grade multi-modal evidence collection, large scale predictive modeling and advanced data analytics. Additionally we are hiring out a new Advanced Analytics Incubator in NY as well as a Digital Health Measurement Science team, focused on novel digital symptom collection for use in trials as well as routine care. If you are interested in joining our team and contributing to our approach, please reach out today!
Feb 2020 - Feb 2024
Mar 2019 - Feb 2020
Global Head, Patient Centered Outcomes Research For Oncology
Spent 7+ years in industry where I built and led a diverse team of Outcomes Research Scientists to create and implement strategies to quantify the patient’s voice to better understand the impact of new therapies. This strengthened decision making across the development lifecycle while supporting regulatory approval, access, reimbursement, and medical communication post launch. This included but was not limited to: endpoint development (performance tests, digital health, clinical outcome assessments), qualitative and quantitative research, treatment preference and satisfaction, burden of illness, and influencing the external regulatory policy environment to enable success at the molecule program level.Additionally I led the US & EU regulatory patient-focused dug development policy, across all disease areas. • Grew and established a new function (e.g. Budget and FTE) in a large, complex organization. Developed a team from 2 FTE to 12 FTE in < 3 years by demonstrating business value.• Acknowledged leader in the field of patient relevant endpoints, invited to present and co-lead multiple initiatives with Friends of Cancer Research,ASCO, the Brookings Institute, and FDA
Aug 2012 - Feb 2019
Senior Patient Reported Outcomes Scientist- Oncology
Responsible for development and implementation of OR strategy and endpoints for multiple development and marketed products• Proposed and received positive CHMP feedback for novel PRO endpoint for gastric cancer• Developed, validated, published novel questionnaire (RASQ) to differentiate between IV and sub-cutaneous delivery of Mabthera• Co-chair Critical Path/FDA multi-industry consortium, Non-Small Cell Lung Cancer working group, to develop novel instrument and endpoint using patient reported outcomes of key lung cancer symptoms for FDA label.
Nov 2011 - Jul 2012
Director, Health Economics And Outcomes Research
Clinical Development and Medical Affairs, OncologyHEOR lead for multiple pipeline and in-line products: responsible for development and implementation of HEOR strategy to generate evidence to demonstrate product value to key stakeholders from Phase 1 through post approval, and facilitate global reimbursement at target price.Highlights include:• Assessment and management of the clinical course and patient impact of the side-effects of targeted therapies (e.g. upper and lower GI, Dermatologic). • Development and implementation of novel side effect treatment management guidelines• Design of novel adverse event intervention trial: https://clinicaltrials.gov/ct2/show/NCT01465802?term=Archer1042&rank=1• Evidence generation for access and reimbursement of personalized medicines with companion diagnostics
Dec 2010 - Oct 2011
Jun 2009 - Dec 2010
Nov 2006 - May 2009
Program Manager, Global Clinical Technology
Leadership over a 10 person team and research exploring the pathodynamics of drug induced liver injury and Torsades by applying novel statistical and mathematical methods (e.g. stochastic differential equations and predictive modeling combined with advanced computing) in partnership with OSU's Mathematical Biosciences Institute. An early incantation if what would become machine learning analytics applied to drug development.
Jun 2003 - Feb 2006
4 education records
Alicyn Campbell education
Master Of Public Health (Mph), Epidemiology And Health Outcomes Research
The University Of Connecticut School Of Medicine
Bachelor Of Arts - Ba
Trinity College-Hartford
Attended One Year, Full Academic Merit Scholorship
Reed College
Multi-Polarization And Multi-Frequency Synthetic Aperture Radar Research, 1991-1996 (Summers)
Summer Fellowships At Nasa / Jet Propulsion Laboratory
FAQ
Frequently asked questions about Alicyn Campbell
Quick answers generated from the profile data available on this page.
What company does Alicyn Campbell work for?
Alicyn Campbell works for @ Stealth Technology NewCo.
What is Alicyn Campbell's role at @ Stealth Technology NewCo?
Alicyn Campbell is listed as Founder and Chief Executive Officer at @ Stealth Technology NewCo.
What is Alicyn Campbell's email address?
AeroLeads has found 1 work email signal at @astrazeneca.com for Alicyn Campbell at @ Stealth Technology NewCo.
Where is Alicyn Campbell based?
Alicyn Campbell is based in United States while working with @ Stealth Technology NewCo.
What companies has Alicyn Campbell worked for?
Alicyn Campbell has worked for @ Stealth Technology Newco, Evidentley, Patient Relevant Evidence, Evinova, and Astrazeneca.
How can I contact Alicyn Campbell?
You can use AeroLeads to view verified contact signals for Alicyn Campbell at @ Stealth Technology NewCo, including work email, phone, and LinkedIn data when available.
What schools did Alicyn Campbell attend?
Alicyn Campbell holds Master Of Public Health (Mph), Epidemiology And Health Outcomes Research from The University Of Connecticut School Of Medicine.
What skills is Alicyn Campbell known for?
Alicyn Campbell is listed with skills including Oncology, Clinical Development, Clinical Trials, Outcomes Research, Health Economics, Pharmaceutical Industry, Clinical Research, and Drug Development.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial